Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
228 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (116)
  • Allergy, Asthma, & Immunology (1)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (6)
  • Bone & Muscle (1)
  • Cancer (65)
    • Brain Cancer (2)
    • Breast Cancer (1)
    • Head and Neck Cancer (1)
    • Kidney Cancer (1)
    • Leukemia (2)
    • (-) Lung Cancer (1)
    • Lymphoma (6)
    • Sarcoma (1)
    • Skin Cancer (26)
    • Solid Tumors (3)
  • COVID-19 (Coronavirus) (2)
  • Diabetes (1)
  • Gastrointestinal and Digestive Diseases (1)
  • Hair and Skin Disorders (3)
  • Healthy Volunteers (11)
  • Heart Disease (3)
  • Infectious Disease (1)
  • Kidney Disease (1)
  • Lung Disease (5)
  • Neurological Disorders (4)
  • (-) Obstetrics & Gynecology (2)
    • Contraception (2)
  • Pediatrics (3)
  • Psychiatric Disorders (1)
  • Rehabilitation (1)
  • Transplant (2)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

A study for healthy women seeking birth control using Agile contraceptive patch, AG200-15

Condition: Obstetrics & Gynecology / Contraception
Investigator: Paula Castano, MD, MPH
Status: Closed
The purpose of this study is to assess the effectiveness of AG200-15 which is an investigational birth control patch. AG200-15 is an investigational birth control patch being developed for use by women who wish to use a skin patch to prevent pregnancy. It contains LNG (levonorgestral) and EE (ethinyl estradiol), which are…
Read More

COPERNICUS: A study to treat non-small cell lung cancer (NSCLC)

Condition: Cancer / Lung Cancer
Investigator: Catherine Shu, MD
Status: Closed
The purpose of this study is to understand more about the combination of amivantamab and lazertinib in non-small cell lung cancer (NSCLC) who have a specific mutation in the EGFR (epidermal growth factor receptor) gene and have not had prior treatment for their disease. The Food and Drug Administration (FDA) has not approved the combination of amivantamab…
Read More

VeraCept Phase III

Condition: Obstetrics & Gynecology / Contraception
Investigator: Paula Castano, MD, MPH
Status: Closed
We are asking you to participate in this research study because you are a woman of child-bearing age or potential and interested in using an intrauterine device (IUD) for birth control for up to 5 years.
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science